Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sunshine Biopharma Inc. - Common stock (NQ:SBFM)

1.670 -0.040 (-2.33%)
Streaming Delayed Price Updated: 12:23 PM EST, Nov 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 40,010
Open 1.650
Bid (Size) 1.670 (200)
Ask (Size) 1.690 (300)
Prev. Close 1.710
Today's Range 1.650 - 1.710
52wk Range 1.169 - 3.900
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Sunshine Biopharma Scores a Major Regulatory Win to Market Domperidone in Canada (NASDAQ: SBFM)
Via ACCESS Newswire
Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea
Via ACCESS Newswire

Performance

YTD
-46.6%
-46.6%
1 Month
+9.2%
+9.2%
3 Month
+14.4%
+14.4%
6 Month
+31.5%
+31.5%
1 Year
-42.2%
-42.2%

More News

Read More
Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline
Via ACCESS Newswire
Sunshine Biopharma Stock Powers Ahead Following Launch Of Generic Cholesterol-Lowering Drug By Canadian Unit
Via Stocktwits
Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin
Via ACCESS Newswire
Sunshine Biopharma Stock is 34% Higher Since September as Investors Reward Performance Combined with Innovation (NASDAQ: SBFM)
Via AB Newswire
Sunshine Biopharma is Proving That Riding Momentum is an Effective Strategy (NASDAQ:SBFM)
Via ACCESS Newswire
Sunshine Biopharma Proves Microcap Ambition Can Deliver Large-Cap Level Execution (NASDAQ: SBFM)
Via ACCESS Newswire
Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience
Via ACCESS Newswire
Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Sunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge In
Via Stocktwits
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market
Via ACCESS Newswire
Sunshine Biopharma Unit Launches Generic Anticonvulsant In Canada: Retail Sees ‘Huge Potential’
Via Stocktwits
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
Via ACCESS Newswire
Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year
Via ACCESS Newswire
Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market
Via ACCESS Newswire
Sunshine Biopharma Boosts Retail Trader Appeal After Canadian Launch Of Generic Cancer Drug
Via Stocktwits
The market is filled with gapping stocks in Monday's session.
Via Chartmill
What's going on in today's pre-market session
Via Chartmill
Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion
Via ACCESS Newswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Sunshine Biopharma Inc. - Common stock publicly traded?
Yes, Sunshine Biopharma Inc. - Common stock is publicly traded.
What exchange does Sunshine Biopharma Inc. - Common stock trade on?
Sunshine Biopharma Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sunshine Biopharma Inc. - Common stock?
The ticker symbol for Sunshine Biopharma Inc. - Common stock is SBFM on the Nasdaq Stock Market
What is the current price of Sunshine Biopharma Inc. - Common stock?
The current price of Sunshine Biopharma Inc. - Common stock is 1.670
When was Sunshine Biopharma Inc. - Common stock last traded?
The last trade of Sunshine Biopharma Inc. - Common stock was at 11/04/25 12:23 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.